STOCK TITAN

Guardant Health (GH) director reports RSU vesting, 5,092 shares and new 2,711 RSU grant

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardant Health director Ian T. Clark reported equity compensation activity tied to the 2026 Annual Meeting of Stockholders. A previously granted restricted stock unit (RSU) award vested in full on June 17, 2026 and was exercised into 5,092 shares of common stock, bringing indirect holdings in a family trust to 8,067 shares.

Clark also received a new grant of 2,711 RSUs on June 17, 2026. These RSUs convert into the same number of common shares and are scheduled to vest in full on the one-year anniversary of the grant date or on the date of Guardant Health’s next annual stockholder meeting, whichever occurs earlier. All reported transactions are acquisitions related to awards rather than open-market buying or selling.

Positive

  • None.

Negative

  • None.
Insider CLARK IAN T
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 5,092 $0.00 $0.00
Grant/Award Restricted Stock Units 2,711 $0.00 $0.00
Exercise Common Stock 5,092 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 2,711 shares (Direct); Common Stock — 8,067 shares (Indirect, By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account)
Footnotes (3)
  1. F1. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
  2. F2. Not applicable for Restricted Stock Units.
  3. F3. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
RSUs converted to common 5,092 shares RSU award vested and exercised on June 17, 2026
Common shares indirectly held 8,067 shares Held by The Thornton-Clark Family Trust after RSU conversion
New RSU grant 2,711 RSUs Granted June 17, 2026, vesting on one-year anniversary or next annual meeting
Derivative exercises 1 transaction, 5,092 shares Exercise or conversion of derivative security reported in Form 4
Restricted Stock Units financial
"The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Annual Meeting of Stockholders financial
"the 2026 Annual Meeting of Stockholders which was held on June 17, 2026"
Family Trust financial
"By The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity transactions did Ian T. Clark report in Guardant Health (GH) Form 4?

Ian T. Clark reported equity compensation activity, not open-market trades. An earlier RSU award vested and converted into 5,092 common shares, and he received a new grant of 2,711 RSUs, all dated June 17, 2026.

How many Guardant Health (GH) shares did Ian T. Clark acquire through RSU vesting?

A fully vested RSU award converted into 5,092 Guardant Health common shares. After this conversion, 8,067 common shares were reported as indirectly held through The Thornton-Clark Family Trust associated with Ian T. Clark.

Were there any open-market stock sales or purchases by Ian T. Clark in this Guardant Health (GH) filing?

No open-market sales or purchases were reported. All three transactions were coded as acquisitions, reflecting RSU vesting, derivative exercise, and a new RSU grant rather than discretionary market trading in Guardant Health shares.

What new restricted stock units did Ian T. Clark receive from Guardant Health (GH)?

Ian T. Clark received a grant of 2,711 restricted stock units on June 17, 2026. Each RSU represents one Guardant Health common share and will vest in full on the one-year anniversary of the grant or the next annual stockholder meeting, whichever occurs earlier.

Are Ian T. Clark’s Guardant Health (GH) holdings direct or through a trust?

Following the RSU conversion, 8,067 Guardant Health common shares were reported as held indirectly by The Thornton-Clark Family Trust. The new 2,711 RSUs are reported as directly owned in Clark’s name until they convert into common stock.

What event triggered the RSU vesting for Ian T. Clark at Guardant Health (GH)?

The RSU vesting was tied to Guardant Health’s 2026 Annual Meeting of Stockholders held on June 17, 2026. A prior RSU award vested in full on that meeting date, leading to the issuance of 5,092 common shares to an associated trust.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CLARK IAN T

(Last)(First)(Middle)
3100 HANOVER STREET

(Street)
PALO ALTO CALIFORNIA 94304

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/17/2026M5,092A$08,067IBy The Thornton-Clark Family Trust, J Thornton-Clark & I Clark TTE Account
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$006/17/2026M5,092 (1) (2)Common Stock5,092$00D
Restricted Stock Units$006/17/2026A2,711 (3) (2)Common Stock2,711$02,711D
Explanation of Responses:
1. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
2. Not applicable for Restricted Stock Units.
3. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
Remarks:
/s/ John G. Saia, as attorney-in-fact for Ian T. Clark06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)